tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMMP Stock Latest News

Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
RatingsImmutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
21d ago
IMMP
Immutep announces first patient dosed in TACTI-004 Phase III trial
PremiumThe Fly
Immutep announces first patient dosed in TACTI-004 Phase III trial
22d ago
IMMP
Immutep announces poster presentation for the TACTI-004 Phase III trial
PremiumThe Fly
Immutep announces poster presentation for the TACTI-004 Phase III trial
28d ago
MRK
IMMP
Immutep Reports Increased Revenue Amid Growing R&D Costs
PremiumCompany Announcements
Immutep Reports Increased Revenue Amid Growing R&D Costs
1M ago
IMMP
Immutep Reports Increased Revenue Amid Rising R&D Costs
PremiumCompany Announcements
Immutep Reports Increased Revenue Amid Rising R&D Costs
2M ago
6K
IMMP
Immutep Advances to Phase III with Key Approvals and Promising Trial Results
PremiumCompany AnnouncementsImmutep Advances to Phase III with Key Approvals and Promising Trial Results
2M ago
6K
IMMP
Immutep promotes Christian Mueller to CDO, CMO Florian Vogl to depart
Premium
The Fly
Immutep promotes Christian Mueller to CDO, CMO Florian Vogl to depart
3M ago
IMMP
Immutep reports Q2 cash receipts from customers A$8,000
Premium
The Fly
Immutep reports Q2 cash receipts from customers A$8,000
3M ago
IMMP
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
PremiumThe Fly
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
3M ago
IMMP
Immutep completes patient enrollment for INSIGHT-003
PremiumThe Fly
Immutep completes patient enrollment for INSIGHT-003
3M ago
IMMP
Immutep announces initial safety data from Phase I study on IMP761
PremiumThe Fly
Immutep announces initial safety data from Phase I study on IMP761
4M ago
IMMP
Immutep, Monash University announce publication on human LAG-3
PremiumThe Fly
Immutep, Monash University announce publication on human LAG-3
4M ago
IMMP
Immutep announces results from Cohort B of TACTI-003 trial
PremiumThe FlyImmutep announces results from Cohort B of TACTI-003 trial
4M ago
IMMP
Immutep announces initiation of TACTI-004 Phase III trial
Premium
The Fly
Immutep announces initiation of TACTI-004 Phase III trial
4M ago
IMMP
Immutep Reports Promising Phase II Sarcoma Trial Results
Premium
Company Announcements
Immutep Reports Promising Phase II Sarcoma Trial Results
5M ago
6K
IMMP
Immutep price target raised to $7 from $6 at Baird
PremiumThe Fly
Immutep price target raised to $7 from $6 at Baird
5M ago
IMMP
Immutep’s Promising Lung Cancer Trial Results
PremiumCompany Announcements
Immutep’s Promising Lung Cancer Trial Results
5M ago
6K
IMMP
Immutep announces data from INSIGHT-003 trial
PremiumThe Fly
Immutep announces data from INSIGHT-003 trial
5M ago
IMMP
Immutep data from Phase II trial presented at CTOS
PremiumThe Fly
Immutep data from Phase II trial presented at CTOS
5M ago
IMMP
Immutep’s Growth and Advancements Boost Market Visibility
PremiumCompany AnnouncementsImmutep’s Growth and Advancements Boost Market Visibility
6M ago
6K
IMMP
Immutep reports Q1 cash receipts from custmers $20,000
Premium
The Fly
Immutep reports Q1 cash receipts from custmers $20,000
6M ago
IMMP
Immutep announces first-in-human phase I study of IMP761
Premium
The Fly
Immutep announces first-in-human phase I study of IMP761
6M ago
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >